Clinical trial · Interventional
Obstructive Sleep Apnea Syndrome After Oropharyngeal Cancer Treatment
NCT02881723CI-TRIAL-00023679unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The level of knowledge about the consequences of oropharyngeal cancer treatment on sleep quality remains poor. Because of a high level of risk of developing an Obstructive Sleep Apnea Syndrome (OSAS), an accurate evaluation of the prevalence, of the risk factors and of the impact on quality of life is important in order to propose preventive and therapeutic solutions to these patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Obstructive Sleep Apnea Syndrome | — | UNRESOLVED | — |
| Oropharyngeal Cancer | Malignant Oropharyngeal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radio- chemotherapy | Radiation | — | UNRESOLVED |
| Surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Treatment for oropharyngeal cancer by surgery
- description
- Disease-free patients treated for locally advanced oropharyngeal cancer for over 12 months by surgery
- interventionNames
- Procedure: Surgery
- type
- EXPERIMENTAL
- label
- Treatment for oropharyngeal cancer by radio-chemotherapy
- description
- Disease-free patients treated for locally advanced oropharyngeal cancer for over 12 months by radio-chemotherapy
- interventionNames
- Radiation: Radio- chemotherapy
Primary outcomes (1)
- measure
- Measuring the index of apneas and hypopneas (IAH), defined by the number of apneas per sleep hour
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient aged over 18 years old, male or female; * Patient treated for a first oropharyngeal cancer located in upper airways (velum, side walls, back wall, base of tongue, vallecules), locally advanced, rated T3 or T4, whatever the stage N and M0; * Patient who received curative treatment either surgical (excision and reconstruction free flap) with adjuvant radiotherapy or concurrent chemoradiotherapy; * Treatment completed at least 12 months prior to study entry; * Patient whose cancer disease is under control at exam time; * Subject affiliated to a social security scheme; * Subject agreeing to participate in the study and who signed the informed consent form. Exclusion Criteria: * Minor patient * No affiliation to a social security scheme (beneficiary or assignee); * Patient who did not signed the informed consent form * Patient with neurological disease that can affect the upper airways function * Patient has already been treated for head and neck cancer; * Patient has a lesion classified T1 or T2 or M1; * Patient has received different treatments: surgical resection without reconstruction, only radiotherapy * Unweaned alcoholic patients
References
Publications (0)
Data not yet available
No reference posted for this study.